has function has role immunizes against disease immunizes recipient lung cancer Homo sapiens conjugate vaccine therapeutic vaccine function conjugate vaccine role vaccine in clinical trial role lung cancer vaccine therapeutic cancer vaccine GD2L, GD3L, Globo H, fucosyl GM1, and N-propionylated polysialic acid KLH conjugate vaccine Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C97034 A cancer vaccine used to treat patients with small cell lung cancer by using several components (small cell lung cancer targets) that have been tested individually in patients with small cell lung cancer or other cancers (GD2, GD3, Globo H, Fucosyl GM1 and N-propionylated polysialic acid) so that the body will make antibodies to the vaccine which will also react against the cancer. Two other substances (KLH and OPT-821) are added which boost the immune system. Vaccination with the pentavalent KLH conjugate vaccine may induce production of IgG and IgM antibodies as well as an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumors expressing any of these antigens. 2524 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6275 8705 Gene name: GD 2 cancer vaccine 2583 6489 6275 Gene name: Globo H Hayleigh Kahn Gene name: fucosyl GM1 NCT: https://clinicaltrials.gov/study/NCT01349647 Gene name: GD3